It would not be an exaggeration to state that the goal of attempting to surgically maximally cytoreduce diffuse intraperitoneal ovarian cancer represents one of the most unique standard-of-care ...

Evidence on the safety of cytoreduction surgery with hyperthermic intraoperative peritoneal chemotherapy for peritoneal carcinomatosis shows frequent and serious but well-recognised complications.

For the past four decades, the standard management of patients with advanced ovarian cancer has been primary cytoreductive surgery followed by chemotherapy. Numerous studies have demonstrated that ...

Despite aggressive primary surgical cytoreduction and platinum-based chemotherapy, many women diagnosed with advanced epithelial ovarian cancer who achieve primary remission will experience disease ...

The association between residual tumor volume after primary cytoreduction and survival was less consistent in patients with low-grade serous ovarian carcinoma (LGSOC) compared with other histology ...

There is not enough evidence about how well this procedure works or how safe it is. This type of procedure can cause complications. So it can only be done with special arrangements. This means you ...